Net Cash Provided by (Used in) Investing Activities in USD of GT Biopharma, Inc. from 2011 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
GT Biopharma, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and change rate from 2011 to 2024.
  • GT Biopharma, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending 31 Mar 2024 was $5.03K.
  • GT Biopharma, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2024 was $12.9M.
  • GT Biopharma, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was -$2.01M.
  • GT Biopharma, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was $12.1M.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Change (%)

GT Biopharma, Inc. Quarterly Net Cash Provided by (Used in) Investing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $5.03K +$6.99M 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025
Q1 2023 -$6.99M* -$10.5M 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q1 2022 $3.53M* 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q1 2019 $0 +$2K 01 Jan 2019 31 Mar 2019 10-Q 15 May 2019
Q1 2018 -$2K -$2K 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019
Q1 2017 $0 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018

GT Biopharma, Inc. Annual Net Cash Provided by (Used in) Investing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $12.9M* +$14.9M 01 Jan 2024 31 Dec 2024 10-K 21 Feb 2025
2023 -$2.01M -$14.2M 01 Jan 2023 31 Dec 2023 10-K 21 Feb 2025
2022 $12.1M* +$35.2M 01 Jan 2022 31 Dec 2022 10-K 26 Mar 2024
2021 -$23M* -$23M 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023
2020 $0 -$200K -100% 01 Jan 2020 31 Dec 2020 10-K 16 Apr 2021
2019 $200K +$236K 01 Jan 2019 31 Dec 2019 10-K 16 Apr 2021
2018 -$36K -$32K -800% 01 Jan 2018 31 Dec 2018 10-K 27 Mar 2020
2017 -$4K -$4K 01 Jan 2017 31 Dec 2017 10-K 29 Mar 2019
2016 $0 +$1K 01 Jan 2016 31 Dec 2016 10-K 01 Mar 2018
2015 -$1K +$5K +83.3% 01 Jan 2015 31 Dec 2015 10-K/A 28 Feb 2018
2014 -$6K -$6K 01 Jan 2014 31 Dec 2014 10-K/A 28 Feb 2018
2013 $0 +$2K 01 Jan 2013 31 Dec 2013 10-K 31 Mar 2015
2012 -$2K -$2K 01 Jan 2012 31 Dec 2012 10-K 08 Jan 2015
2011 $0 01 Jan 2011 31 Dec 2011 10-K 18 Nov 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.